Print（PDF/674KB） Aug. 05, 2025 Corporate

Notice Regarding the Completion of the CRAFT Regenerative Medicine and Cell Therapy Manufacturing Facility

Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Toru Kimura) today announced that S-RACMO Co., Ltd. (Head Office: Suita, Osaka; President and CEO: Atsushi Tsuchida), the joint venture with and Sumitomo Chemical Co., Ltd. (Head Office: Tokyo, Japan; President: Nobuaki Mito), has completed the construction of the third building of its regenerative medicine and cell therapy manufacturing facility, called “CRAFT” (Center for Regenerative Medicine and Future Therapy). This expansion represents a significant step forward in strengthening S-RACMO’s manufacturing capabilities and supporting the continued growth of its regenerative and cellular medicine business.

Please refer to the attached document for further details.